Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Prim. 2020;6:1–22.

Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

Article  PubMed  Google Scholar 

Li Q, Tie Y, Alu A, Ma X, Shi H. Targeted therapy for head and neck cancer: signaling pathways and clinical studies. Sig Transduct Target Ther. 2023;8:1–28.

Google Scholar 

Zhou G, Liu Z, Myers JN. TP53 mutations in head and neck squamous cell carcinoma and their impact on disease progression and treatment response. J Cell Biochem. 2016;117:2682–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chung CH, Ely K, McGavran L, Varella-Garcia M, Parker J, Parker N, et al. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas. J Clin Oncol. 2006;24:4170–6.

Article  CAS  PubMed  Google Scholar 

Iglesias-Bartolome R, Martin D, Gutkind JS. Exploiting the head and neck cancer oncogenome: widespread PI3K-mTOR pathway alterations and novel molecular targets. Cancer Discov. 2013;3:722–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leemans CR, Braakhuis BJM, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer. 2011;11:9–22.

Article  CAS  PubMed  Google Scholar 

Furukawa M, Xiong Y. BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase. Mol Cell Biol. 2005;25:162–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kansanen E, Kuosmanen SM, Leinonen H, Levonen A-L. The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer. Redox Biol. 2013;1:45–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ramos-Gomez M, Kwak MK, Dolan PM, Itoh K, Yamamoto M, Talalay P, et al. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc Natl Acad Sci USA. 2001;98:3410–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ramos-Gomez M, Dolan PM, Itoh K, Yamamoto M, Kensler TW. Interactive effects of nrf2 genotype and oltipraz on benzo[a]pyrene-DNA adducts and tumor yield in mice. Carcinogenesis. 2003;24:461–7.

Article  CAS  PubMed  Google Scholar 

Chio IIC, Jafarnejad SM, Ponz-Sarvise M, Park Y, Rivera K, Palm W, et al. NRF2 promotes tumor maintenance by modulating mrna translation in pancreatic cancer. Cell. 2016;166:963–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lignitto L, LeBoeuf SE, Homer H, Jiang S, Askenazi M, Karakousi TR, et al. Nrf2 activation promotes lung cancer metastasis by inhibiting the degradation of Bach1. Cell. 2019;178:316–29.e18.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fox DB, Garcia NMG, McKinney BJ, Lupo R, Noteware LC, Newcomb R, et al. NRF2 activation promotes the recurrence of dormant tumour cells through regulation of redox and nucleotide metabolism. Nat Metab. 2020;2:318–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Taniguchi S, Elhance A, Van Duzer A, Kumar S, Leitenberger JJ, Oshimori N. Tumor-initiating cells establish an IL-33–TGF-β niche signaling loop to promote cancer progression. Science. 2020;369:eaay1813.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feng L, Zhao K, Sun L, Yin X, Zhang J, Liu C, et al. SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis. J Transl Med. 2021;19:367.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Singh A, Daemen A, Nickles D, Jeon S-M, Foreman O, Sudini K, et al. NRF2 activation promotes aggressive lung cancer and associates with poor clinical outcomes. Clin Cancer Res. 2021;27:877–88.

Article  CAS  PubMed  Google Scholar 

Forstrom JW, Zakowski JJ, Tappel AL. Identification of the catalytic site of rat liver glutathione peroxidase as selenocysteine. Biochemistry. 1978;17:2639–44.

Article  CAS  PubMed  Google Scholar 

Schwarz M, Löser A, Cheng Q, Wichmann-Costaganna M, Schädel P, Werz O, et al. Side-by-side comparison of recombinant human glutathione peroxidases identifies overlapping substrate specificities for soluble hydroperoxides. Redox Biol. 2023;59:102593.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Esworthy RS, Doroshow JH, Chu F-F. The beginning of GPX2 and 30 years later. Free Radic Biol Med. 2022;188:419–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee E, Choi A, Jun Y, Kim N, Yook JI, Kim SY, et al. Glutathione peroxidase-1 regulates adhesion and metastasis of triple-negative breast cancer cells via FAK signaling. Redox Biol. 2020;29:101391.

Article  CAS  PubMed  Google Scholar 

Cheng L, He Q, Liu B, Chen L, Lv F, Li X, et al. SGK2 promotes prostate cancer metastasis by inhibiting ferroptosis via upregulating GPX4. Cell Death Dis. 2023;14:1–14.

Article  Google Scholar 

Ren Z, Liang H, Galbo PM, Dharmaratne M, Kulkarni AS, Fard AT, et al. Redox signaling by glutathione peroxidase 2 links vascular modulation to metabolic plasticity of breast cancer. Proc Natl Acad Sci USA. 2022;119:e2107266119.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ding Y, Chen X, Liu C, Ge W, Wang Q, Hao X, et al. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells. J Hematol Oncol. 2021;14:19.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peng D, Hu T, Soutto M, Belkhiri A, Zaika A, El-Rifai W. Glutathione peroxidase 7 has potential tumour suppressor functions that are silenced by location-specific methylation in oesophageal adenocarcinoma. Gut. 2014;63:540–51.

Article  CAS  PubMed  Google Scholar 

Nguyen TTM, Nguyen TH, Kim HS, Dao TTP, Moon Y, Seo M, et al. GPX8 regulates clear cell renal cell carcinoma tumorigenesis through promoting lipogenesis by NNMT. J Exp Clin Cancer Res. 2023;42:42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang M, Zhu X, Shen Y, He Q, Qin Y, Shao Y, et al. GPX2 predicts recurrence-free survival and triggers the Wnt/β-catenin/EMT pathway in prostate cancer. PeerJ. 2022;10:e14263.

Article  PubMed  PubMed Central  Google Scholar 

Lei Z, Tian D, Zhang C, Zhao S, Su M. Clinicopathological and prognostic significance of GPX2 protein expression in esophageal squamous cell carcinoma. BMC Cancer. 2016;16:410.

Article  PubMed  PubMed Central  Google Scholar 

Ahmed KM, Veeramachaneni R, Deng D, Putluri N, Putluri V, Cardenas MF, et al. Glutathione peroxidase 2 is a metabolic driver of the tumor immune microenvironment and immune checkpoint inhibitor response. J Immunother Cancer. 2022;10:e004752.

Article  PubMed  PubMed Central  Google Scholar